- Market Realist•3 days ago
23.1% of analysts gave United Therapeutics (UTHR) a “buy” recommendation while 69.2% of analysts rated the company a “hold.”
- Zacks•4 days ago
The combination of Lilly's Zacks Rank #3 and +1.18% ESP makes us very confident in looking for a positive earnings beat on Jul 26.
After hours: 86.26-0.17 (-0.20%) as of 4:20 PM EDT
|Bid||86.42 x 10100|
|Ask||86.44 x 500|
|52wk Range||55.00 - 133.62|
|Day's Range||84.99 - 86.89|
|Avg Vol (3m)||1,094,098|
As of 4:00 PM EDT. Market closed.